Sharechat Logo

Dorchester makes second repayment

Monday 30th March 2009

Text too small?
Dorchester Finance paid the second installment to debenture holders under its deferred repayment plan and said it is on track to meet the next payment on June 30.

The unit of Dorchester Pacific is "currently ahead of expectations in relation to our cash position," executive director Paul Byrnes said.

Repayments to date amount to 25% of the total it agreed to find for secured debenture holders owed a total of $164 million. Under the plan agreed with investors, Dorchester will make a total of 12 payments over the next three years. Unsecured note-holders are owed about $8 million.

Dorchester Pacific turned to a net loss in its first half after writing off the value of its stake in St Laurence and taking an impairment charge against assets. Under its repayment plan, investors won't receive interest payments though they're entitled to a profit share arrangement at the end of the three-year period.

Shareholder equity plummeted 90% to $6.6 million from $64.4 million in the first half, and directors confirmed an interim dividend would not be paid to shareholders.

The company's stock last traded at five cents on March 26 and has tumbled 91% in the past 12 months.

By Jonathan Underhill



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors